2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-VaccinationDNA Virus Infections, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Herpesviridae infectious disease, Infections, Male Urogenital Diseases, Urogenital Diseases, female reproductive system disorder, genital herpes, herpes simplex infectious disease, infectious disease, male reproductive system disorder, sexually transmitted disease, viral infectious disease, viral sexually transmitted diseaseEnrolling by invitationPhase 12026-01-09NCT07330440
Evaluating Safety and Efficacy of Repeat Doses of UB-621in Adult Patients With Recurrent Genital HerpesDNA Virus Infections, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Herpesviridae infectious disease, Infections, Male Urogenital Diseases, Urogenital Diseases, female reproductive system disorder, genital herpes, herpes simplex infectious disease, infectious disease, male reproductive system disorder, sexually transmitted disease, viral infectious disease, viral sexually transmitted diseaseNot yet recruitingPhase 22022-10-03NCT04979975